Functional role of antibodies generated in heifers through immunization with Staphylococcus aureus vaccines in invasion and phagocytosis assays by Renna, María Sol et al.
R E S EA RCH L E T T E R
Functional role of antibodies generated in heifers through
immunization with Staphylococcus aureus vaccines in invasion
and phagocytosis assays
Marıa S. Renna1,2, Elizabet A.L. Pereyra1,2, Celina Baravalle1,2, Cecilia M. Camussone3,4,
Bibiana E. Dallard1,2, Ivan S. Marcipar3,5 & Luis F. Calvinho4,6
1Laboratorio de Biologıa Celular y Molecular Aplicada, Facultad de Ciencias Veterinarias, Universidad Nacional del Litoral, Santa Fe, Argentina;
2Instituto de Ciencias Veterinarias del Litoral (ICIVET-Litoral), Consejo Nacional de Investigaciones Cientıficas y Tecnicas (CONICET), Buenos Aires,
Argentina; 3Concejo Nacional de Investigaciones Cientıficas y Tecnicas, Buenos Aires, Argentina; 4Estacion Experimental Agropecuaria Rafaela,
Instituto Nacional de Tecnologıa Agropecuaria (INTA), Santa Fe, Argentina; 5Facultad de Bioquımica y Ciencias Biologicas, Universidad Nacional
del Litoral, Santa Fe, Argentina; and 6Facultad de Ciencias Veterinarias, Universidad Nacional del Litoral, Santa Fe, Argentina
Correspondence: Marıa S. Renna, Facultad
de Ciencias Veterinarias, Universidad
Nacional del Litoral, Rvdo. Padre Kreder
2805, (3080) Esperanza, Santa Fe, Argentina.
Tel.: +54 3496 420639;
fax: +54 3496 426304;
e-mail: msrenna@fcv.unl.edu.ar
Received 1 August 2014; revised 8 August
2014; accepted 19 August 2014. Final








A successful Staphylococcus aureus vaccine should elicit a long-term antibody
response that prevents establishment of the infection. The aim of the present
study was to evaluate the functional role of antibodies raised against different
S. aureus CP5 vaccines in invasion to bovine mammary epithelial cells (MAC-
T) and phagocytosis by bovine milk macrophages in vitro. Sera and whey from
cows immunized with a whole-cell S. aureus CP5 vaccine adjuvanted with Al
(OH)3 or with ISCOM Matrix, significantly reduced internalization of S. aureus
in MAC-T cells without significant differences between both groups. The effect
of antibodies generated by a S. aureus whole-cell and a lysate vaccine formu-
lated with ISCOM Matrix was also evaluated. Sera and whey from both immu-
nized groups significantly reduced S. aureus internalization in MAC-T cells
without significant differences between both groups. Whey antibodies against
whole-cell and lysate vaccines were also able to inhibit internalization in MAC-
T cells of a heterologous S. aureus strain. In addition, sera from animals vacci-
nated with S. aureus lysate or bacterin promoted milk macrophage phagocyto-
sis. These results provide an insight into the potential mechanisms by which
these vaccines can afford protection to the mammary gland against S. aureus
intramammary infection.
Introduction
Staphylococcus aureus is the most frequently isolated path-
ogen from bovine intramammary infections (IMI) world-
wide (Zecconi et al., 2006). Control of S. aureus IMI is
based on milking-time hygiene, antibiotic therapy and
culling of chronically infected cows. The cure rate of
S. aureus IMI following antibiotic treatment is low and
therefore in many herds the disease is not effectively con-
trolled (Barkema et al., 2006). Due to these limitations,
the development of vaccines to complement current mea-
sures to control S. aureus mastitis is of considerable inter-
est to the milk production industry (Middleton, 2008).
Several experimental immunogens for S. aureus mastitis
control have been evaluated during the last two decades
(reviewed by Pereira et al., 2011). However, only two vac-
cines, composed of S. aureus strain lysates expressing cap-
sular polysaccharides (CP) adjuvanted with Al(OH)3
(LysiginTM, Boehringer Ingelheim Vetmedica Inc.,
St. Joseph, MO) and inactivated S. aureus expressing
slime-associated antigenic complex formulated with an
oil-based adjuvant (Startvac, Laboratorios Hipra, S.A.),
are currently commercially available worldwide. The
mechanisms by which whole-cell or lysate vaccines may
protect the mammary gland against S. aureus have not
been fully explored. Since the main goal of S. aureus mas-
titis vaccination is prevention of new IMI (Middleton,
2008), immunogens that elicit a long-term antibody
response against pathogen factors involved in early
host–pathogen interactions should contribute to prevent
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establishment of the infection. Enhancement of blood
polymorphonuclear neutrophil (PMN) phagocytosis
through production of antibodies raised against S. aureus
CP2 bacterial lysates encapsulated in microspheres has
been demonstrated (O’Brien et al., 2001). In addition, it
has been shown that S. aureus CP5 whole cell and lysate
vaccine formulated with ISCOM Matrix adjuvant are able
to stimulate strong antibody responses in blood and milk
that increase PMN opsonic capacity (Camussone et al.,
2014). However, phagocytosis in these studies has been
performed using blood PMN, since once in the milk envi-
ronment these cells undergo morphologic changes and
reduced phagocytic activity (Paape et al., 2003). Macro-
phages are the major cell type in dry mammary gland
secretions, colostrum and milk (Rainard & Riollet, 2006);
among several other functions, they recognize microor-
ganisms, alert the immune system, recruit PMN and initi-
ate an inflammatory reaction (reviewed by Mosser &
Edwards, 2008). Although macrophage bactericidal capa-
bility is considered limited, these cells have receptors for
IgG1 and IgG2 and actively phagocytose bacterial patho-
gens (Desiderio & Campbell, 1980). However, there is no
information about the effect of antibodies generated fol-
lowing immunization with S. aureus whole-cell and lysate
vaccines on phagocytosis by milk macrophages.
The ability of S. aureus to attach to and internalize into
mammary epithelial cells (MEC) is instrumental to mam-
mary gland colonization and development of IMI (Alme-
ida et al., 1996; Dziewanowska et al., 1999; Kerro Dego
et al., 2002; Zecconi & Scali, 2013). Several studies have
addressed the role of antibodies directed against key anti-
gens involved in adherence to/invasion of MEC (Olmsted
& Norcross, 1992; O’Brien et al., 2001; Shkreta et al.,
2004; Nour El-Din et al., 2006). However, there is little
information about the inhibition of adherence to MEC by
antibodies raised against a S. aureus cell lysate (O’Brien
et al., 2001). In this study, the role of antibodies raised
against a S. aureus CP5 whole-cell vaccine formulated
with Al(OH)3 or ISCOM Matrix and against a whole-cell
and lysate vaccines formulated with ISCOM Matrix in
phagocytosis by bovine milk macrophage and invasion of
MEC in vitro was evaluated.
Materials and methods
Immune sera and whey
Sera and whey were obtained from two previous experi-
ments. In the first, pregnant heifers were vaccinated with
a whole-cell vaccine composed of S. aureus CP5 strain
(Reynolds) (Fournier et al., 1987) formulated with 15%
Al(OH)3 (Alhydrogel
TM), the same vaccine formulated
with 2 mg per dose of immune-stimulating complexes
(ISCOM Matrix, kindly supplied by Isconova, Uppsala,
Sweden) or a placebo consisting of sterile saline solution
(Camussone et al., 2013). In the second study, pregnant
heifers were vaccinated with a whole-cell and a bacterial
lysate vaccine of S. aureus CP5 strain (Reynolds) formu-
lated with 2 mg per dose of ISCOM Matrix and a placebo
consisting of sterile saline solution and adjuvant (2 mg
ISCOM Matrix per dose) (Camussone et al., 2014). In
both experiments, heifers were injected subcutaneously
with 1 mL of vaccine in the supramammary lymph node
area, 45 and 15 days before the expected calving date.
Heifers were bled by puncture of the coccygeal vein
before each inoculation, and on day 7 after calving blood
was allowed to clot and sera were collected via centrifuga-
tion. After parturition, aseptic quarter foremilk samples
were collected on day 7 according to standard procedures
(Oliver et al., 2004). An aliquot of 500 lL of milk from
each quarter was used to prepare a composite sample.
Samples were centrifuged at 300 g for 15 min; superna-
tants were collected and stored at 20 °C until processed.
Sera and whey collected from heifers immunized with
S. aureus bacterins and lysates showed significantly higher
specific antibody levels (IgG and IgG2 subtype) compared
with nonvaccinated controls (Camussone et al., 2013,
2014). Sera and whey from day 7 post calving were used
for adherence/internalization and phagocytosis assays
since this was the period at which the highest specific
antibody levels were detected (Camussone et al., 2013,
2014).
Cell culture
The established bovine mammary epithelial cell line
(MAC-T; Huynh et al., 1991) was generously provided by
Dr. C. Porporatto, Universidad Nacional de Villa Marıa,
Cordoba, Argentina. MAC-T cells were grown in Dul-
becco’s modified Eagle’s medium (DMEM, Gibco BRL,
Grand Island, NY) supplemented with 10% heat-inacti-
vated fetal bovine serum (Gibco BRL), insulin
(5 lg mL1), hydrocortisone (1 lg mL1), penicillin
(100 U mL1), and streptomycin sulfate (100 lg mL1)
(Sigma Chemical Co., St. Louis, MO). Prior to each
experiment, MAC-T cells were seeded at 6 9 104 cells/
well in 24-well tissue culture plates and grown for 3 days
at 37 °C with 5% CO2.
Bacteria
Staphylococcus aureus Reynolds and a S. aureus isolate
(IR61) obtained from a cow with spontaneous clinical
mastitis characterized by classical (Oliver et al., 2004) and
molecular methods (Martineau et al., 1998) were used.
Both strains were cap5 type as determined by conventional
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polymerase chain reaction (PCR), produced CP5 in vitro
(Camussone et al., 2012) and showed different pulsotypes
evaluated by pulsed-field gel electrophoresis (PFGE;
Chung et al., 2000); the similarity between these two
types was < 20%.
MEC internalization assay
The bacterial invasion assay was performed as described
by Almeida et al. (1996) with modifications. Bacteria
were activated from frozen stocks (80 °C) by culture
on Columbia agar with 2.5% NaCl added, incubated
overnight at 37 °C for CP expression induction, and
preincubated with a 1/10 dilution of whey or a 1/100
dilution of sera obtained on day 7 postcalving from
each animal included in the study, for 60 min at 37 C
with gentle shaking. After incubation, the bacterial sus-
pension was co-cultured with a confluent monolayer of
MAC-T cells in DMEM at a multiplicity of infection
(MOI, ratio of S. aureus organisms to cells) of 100. The
number of epithelial cells per well was estimated by
counting in a hemocytometer to determine the bacte-
ria : epithelial cell ratio used during invasion experi-
ments. Monolayers were washed three times with
phosphate-buffered saline (PBS; pH 7.4) and treated
with gentamicin (100 lg mL1, Sigma) in DMEM at
37 °C in 5% CO2 for 2 h to kill extracellular bacteria.
Supernatants were then collected and plated on trypti-
case soy agar (TSA) with 5% calf blood added to verify
killing by gentamicin. Monolayers were then washed
three times with PBS, treated with 0.25% trypsin-0.1%
EDTA (Gibco BRL), and further lysed with Triton
X-100 (Amersham, Arlington Heights, IL) at a final con-
centration of 0.025% (v/v) in sterile distilled water to
release intracellular staphylococci. MAC-T cell lysates
were serially diluted 10-fold, plated on TSA with 5% calf
blood added and incubated overnight at 37 °C. Colony-
forming units per mL (CFU mL1) of S. aureus associ-
ated with MAC-T cells were determined by standard
colony-counting techniques. Each assay was run in
duplicate (for whey-preincubated samples) or in tripli-
cate (for sera-preincubated samples) with three observa-
tions per assay. Data were expressed as intracellular
CFU mL1 or as percentage of internalization relative to
control group (whey from animals that were vaccinated
with a placebo consisting of sterile saline solution con-
sidered as 100% of internalization).
Milk macrophage phagocytosis
Mammary secretions were collected from nonlactating
healthy cows 10–15 days after cessation of milking and
macrophages were isolated as described previously (Doso-
gne et al., 2001). Phagocytosis assay was performed
by flow cytometry using fluorescein isothiocyanate
(FITC)-labeled S. aureus Reynolds as described (Camus-
sone et al., 2013) with modifications. Briefly, 100 lL of
FITC-labeled S. aureus Reynolds suspension (1 9 108
CFU mL1) was incubated with pooled sera for 30 min
at 37 C with gentle shaking. Then, 100 lL of a 1 9 107
cells mL1 suspension of bovine mammary secretion
macrophages was added and incubated for another
30 min at 37 C with gentle shaking. Phagocytosis was
stopped by the addition of NaCl 0.85%/EDTA 0.04%.
Finally, the mixture was stained with ethidium bromide
to quench extracellular fluorescence (Weingart et al.,
1999) and analyzed by flow cytometry (FACSCanto II,
BD Biosciences). The macrophage population was gated
based on forward and side light scatter parameters
(Region 1, R1). Data were collected using a FACSCanto
II flow cytometer (BD Biosciences) and analyzed using
WINMDI software. The percentage of macrophages with
associated bacteria was assessed and the mean fluores-
cence intensity (MFI) was used to estimate the number of
bacteria internalized per positive cell (Zetterlund et al.,
1998).
Statistical analysis
A statistical software package (SPSS version 17.0) was
used to perform statistical analysis. Means of CFU mL1
obtained from adherence/internalization assays in MAC-
T cells and percentages of FITC-positive macrophages in
phagocytosis assays were compared using analysis of var-
iance, followed by Tukey test to detect differences
between pairs. Percentages of internalization in MAC-T
cells were compared by Student’s t-test. The significant
level was set at P < 0.05. Results were expressed as
mean  SEM.
Results
Effect of sera and whey from heifers
immunized with whole cell vaccine formulated
with ISCOM Matrix and Al(OH)3 on
internalization in MAC-T cells
Whey and sera from ISCOM Matrix and Al(OH)3 vacci-
nated groups inhibited internalization of S. aureus in
MAC-T cells (Fig. 1). Staphylococcus aureus internaliza-
tion was inhibited by sera from Al(OH)3 and ISCOM
Matrix immunized groups (P = 0.001 and P = 0.004,
respectively), and by whey from Al(OH)3 and ISCOM
Matrix immunized groups (P = 0.046). No differences
were observed between the two vaccinated groups (for
sera: P = 0.495 and for whey: P = 0.741).
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Effect of sera and whey from heifers
immunized with whole-cell or lysate vaccine
formulated with ISCOM Matrix on
internalization in MAC-T cells
Whey and sera from both vaccinated groups formulated
with ISCOM Matrix inhibited internalization of S. aureus
in MAC-T cells (Fig. 2A and B). Staphylococcus aureus
internalization was inhibited by sera from lysate and bac-
terin immunized groups (P = 0.004 and P = 0.005,
respectively), and by whey from lysate and bacterin
immunized groups (P = 0.007 and P = 0.01, respectively).
No differences were observed between the two vaccinated
groups (for sera: P = 0.956 and for whey: P = 0.726). In
addition, the ability of whey from vaccinated groups to
inhibit internalization of a heterologous S. aureus isolate
(IR61) compared with S. aureus Reynolds was evaluated.
Whey from both vaccinated groups inhibited internaliza-
tion of heterologous S. aureus in MAC-T cells in the
same way as the homologous S. aureus strain (P < 0.001)
(Fig. 3). No differences in the percent internalization
between the vaccinated groups were observed (homolo-
gous P = 0.494 and heterologous P = 0.601).
Phagocytosis assays
Sera were used in this assay. First, FITC+ S. aureus Rey-
nolds were pretreated with pooled sera and then incu-
bated with bovine milk macrophages (Fig. 4). Based on
light scatter properties, we defined the Region 1 (R1) to
further analyze macrophage phagocytosis (Fig. 4A). Sera
from animals vaccinated with S. aureus lysate or S. aureus
bacterin enhanced bacterial uptake by milk macrophages
compared with sera from control animals (P = 0.003 for
lysate and P = 0.014 for bacterin) (Fig. 4C). Furthermore,
the MFI of the S. aureus phagocytosis by milk macro-
phages showed an increase when sera from both vacci-
nated groups were used as opsonins compared with sera
from control animals (Fig. 4D) (P = 0.047 for lysate and
P = 0.010 for bacterin). No differences between the two
vaccinated groups were observed for percent phagocytosis
(P = 0.335) or for MFI (P = 0.403). Two individual sera
from groups of vaccinate were evaluated yielding similar
results (data not shown).
Discussion
In this study we compared the functional effects of blood
and milk antibodies generated in pregnant heifers during
immunization with a S. aureus CP5 whole-cell and lysate
vaccine on mammary epithelial cell internalization and
macrophage phagocytosis. A variety of experimental
vaccination studies using the new generation adjuvant
ISCOMs including several organisms and animal species
have been reported (Sun et al., 2009). However, there is
little information available about their use for vaccination
against S. aureus bovine mastitis and this was generated
through the use of defined antigens (Nelson et al., 1991;
Morein et al., 2007). Only recently, the use of this adju-
vant for the formulation of a S. aureus whole-cell and
lysate vaccines has been reported (Camussone et al., 2013,
2014).
(A) (B)
Fig. 1. Effect of antiserum against Staphylococcus aureus Reynolds formulated with ISCOM Matrix and Al(OH)3 on internalization of homologous
strain into bovine MEC. (A) Staphylococcus aureus Reynolds pretreated with 1/10 dilution of whey or (B) 1/100 dilution of sera from heifers
immunized with S. aureus Reynolds in ISCOM Matrix, in Al(OH)3 or sterile saline solution (as control group). Bacteria were co-cultured with
bovine MEC and internalization calculated. Data are expressed as intracellular CFU mL1. Bars represent the mean of eight individual whey per
group run in duplicate (A) or eight individual sera per group run in triplicate (B). Error bars represent the SEM. Different letters correspond to
statistically significant differences (P < 0.05). 254 9 190 mm (300 9 300 DPI).
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We first compared the functional capacity of antibodies
generated during immunization with S. aureus CP5
whole-cell vaccine formulated with Al(OH)3 or with IS-
COM Matrix on internalization assays. Since adherence
to MEC and extracellular matrix proteins is considered
the first step in establishing a bacterial infection, antibod-
ies generated through vaccination could block early host–
pathogen interactions and favor macrophages and neutro-
phil phagocytic activity, thus helping to clear the organ-
ism from the mammary gland (Kerro Dego et al., 2002;
Middleton et al., 2009).
The role of antibodies generated in cows in response to
immunization with different S. aureus vaccines has been
evaluated using adherence/internalization assays (Olmsted
& Norcross, 1992; O’Brien et al., 2001; Shkreta et al.,
2004). In the present study, sera and whey from cows
immunized with whole cell S. aureus Reynolds adjuvanted
with Al(OH)3 and ISCOM Matrix significantly reduced
internalization of S. aureus in bovine MEC, compared
with sera and whey from control animals. Olmsted &
Norcross (1992) examined the effect of serum and milk
antibodies generated in one cow immunized with a
S. aureus whole-cell vaccine on the bacterial adherence to
primary bovine MEC by two different methods, demon-
strating antiadherent capabilities. We decided to use a cell
invasion model in the present study based on the fact
that S. aureus can internalize in MEC (Almeida et al.,
1996) even in the absence of well-characterized adhesive
proteins (Brouillette et al., 2003) and that there is no
information about the ability of antibodies generated by
whole-cell vaccines formulated with classical or new adju-
vants to inhibit bacteria internalization in these cells. A
significant internalization inhibition by sera and whey
from both immunized groups was observed. However, no
significant differences in internalization inhibition
between sera and whey from cows immunized with IS-
COM Matrix or with Al(OH)3 groups were detected,
although sera and whey from ISCOM Matrix-immunized
(A) (B)
Fig. 2. Effect of antiserum against Staphylococcus aureus Reynolds lysate and bacterin on internalization of homologous strains in bovine MEC.
(A) Staphylococcus aureus Reynolds pretreated with 1/10 dilution of whey or (B) 1/100 dilution of sera from heifers immunized with S. aureus
Reynolds lysate, bacterin or sterile saline solution (as control group) in ISCOM Matrix. Bacteria were co-cultured with bovine MEC and
internalization calculated. Data are expressed as intracellular CFU mL1. Bars represent the mean of eight individual whey per group run in
duplicate (a) or eight individual sera per group run in triplicate (b). Error bars represent the SEM. Different letters correspond to statistically
significant differences (P < 0.05). 254 9 190 mm (300 9 300 DPI).
Fig. 3. Effect of antiserum against Staphylococcus aureus Reynolds
lysate and bacterin on internalization of heterologous strains in
bovine MEC. Staphylococcus aureus Reynolds (homologous) and
S. aureus IR61 (heterologous) pretreated with 1/10 dilution of whey
from heifers immunized with S. aureus Reynolds lysate, bacterin or
sterile saline solution (as control group) in ISCOM Matrix. Bacteria
were co-cultured with bovine MEC and internalization calculated.
Data are expressed as percentage of controls (100%). Bars represent
the mean of eight individual whey per group run in duplicate. Error
bars represent the SEM, Different letters correspond to statistically
significant differences (P < 0.05). 254 9 190 mm (300 9 300 DPI).
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animals was shown to have significantly increased IgG
and IgG2 levels compared with those immunized with Al
(OH)3 (Camussone et al., 2013).
The effect of antibodies generated by a S. aureus whole
cell and a lysate vaccines formulated with ISCOM Matrix
was also evaluated in the epithelial cell internalization
model. Preincubation with sera or whey from bacterin
and lysate-immunized animals significantly reduced inter-
nalization of S. aureus in MAC-T cells compared with
sera and whey from control animals; however, no signifi-
cant differences were observed between the two immu-
nized groups. Our findings are in agreement with those
from O’Brien et al. (2001). These authors demonstrated
that sera from cows immunized with a S. aureus CP2
lysate encapsulated in biodegradable microspheres or in
Freund’s incomplete adjuvant, significantly reduced bacte-
rial adherence to primary mammary secretory epithelial
cells cultured on rat tail collagen compared with preim-
mune sera. Staphylococcus aureus expressing CP5, like the
strain used in the present study, has been shown to inter-
fere with staphylococcal adherence to cells in vitro
(P€ohlmann-Dietze et al., 2000; Risley et al., 2007). How-
ever, since CP are not equally expressed during the differ-
ent phases of bacterial growth (Luong et al., 2002),
production of antibodies against antigens involved in the
adherence/internalization process and against CP is desir-
able for vaccine development.
Whey antibodies against whole cell and lysate vaccines
were able to inhibit internalization in MAC-T cells of a
heterologous S. aureus strain. This strain presented
< 20% similarity as evaluated by PFGE with the Reynolds
strain and, although they shared the CP5 type, antibodies
raised against CP are not considered to interfere with
adherence to MEC in vitro (O’Brien et al., 2001). There-
fore, both vaccine formulations generated antibodies
capable of interacting with common cell antigens present
on the bacterial cell wall, suggesting that they may pro-
vide protection against unrelated isolates. Since currently
available commercial vaccines are based either on multi-
ple strains (Middleton, 2008) or on the presence of a
S. aureus common antigen (Prenafeta et al., 2010), the
relative importance of staphylococcal antigens that should
be included as vaccine components for achieving a pro-
tective response deserves further studies.
Macrophages are the predominant cell type in milk
and secretions from nonlactating mammary glands and
are the first immune cells to encounter invading bacteria
(Rainard & Riollet, 2006). Bovine milk macrophages take
part in early interactions with pathogens, express recep-
tors for IgG1 and IgG2, are active phagocytes and are
involved in antigen presentation in association with major
histocompatibility complex (MHC) class I and class II
molecules (Desiderio & Campbell, 1980; Craven, 1983;
Sordillo & Streicher, 2002; Rainard & Riollet, 2006).
(A) (B)
(C) (D)
Fig. 4. Effect of antisera against Staphylococcus aureus Reynolds lysate and S. aureus Bacterin on bovine mammary secretion macrophages
phagocytosis of FITC positive S. aureus Reynolds. FITC-positive S. aureus Reynolds were pretreated with 1/100 dilution of pooled sera from
heifers immunized with S. aureus lysate, S. aureus bacterin or sterile saline solution (as control group) formulated with ISCOM Matrix and then
co-cultured with bovine mammary secretion macrophages for phagocytosis assays by flow cytometry. (A) Representative forward scatter vs. side
scatter density plots showing gate in R1 for further macrophages phagocytosis analysis. (B) Representative histograms showing fluorescence
intensity for macrophages incubated with PBS (empty) or FITC-positive S. aureus Reynolds opsonized with sera from heifers immunized with
S. aureus lysate, bacterin or control groups (gray-filled). Percentages of FITC-positive macrophages (C) or MFI (D) are shown. Error bars represent
the SEM. Different letters correspond to statistically significant differences (P < 0.05). 254 9 190 mm (300 9 300 DPI).
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Several studies have evaluated the opsonic capacity of
antibodies raised against S. aureus whole-cell or lysate
vaccines for bovine blood PMN (Guidry et al., 1991,
1994; Camussone et al., 2013, 2014), since milk PMN
show a markedly decreased activity compared with blood
PMN (Paape et al., 2003). However, there is no informa-
tion about opsonic capacity of sera from vaccinated heif-
ers for bovine milk macrophages. An increase in the
percentage of milk macrophages that phagocytosed
S. aureus, and in the number of bacteria ingested per cell,
was observed when sera from animals vaccinated with
S. aureus lysate or S. aureus bacterin were used as opso-
nins. This is in accordance with previous results from our
laboratory where both neutrophil phagocytic capacity and
the number of bacteria internalized per positive cell were
increased upon opsonization with these sera, which was
attributed to high anti-CP5 IgG levels in both vaccinated
groups (Camussone et al., 2014). Considering that both
macrophage numbers (Hurley, 1989) and IgG levels (Sor-
dillo et al., 1987) increase as mammary involution pro-
gresses, a vaccination booster with whole cells and lysates
shown to achieve high antibody levels at the end of lacta-
tion (Camussone et al., 2014) could therefore favor mac-
rophage activity during this period. However, this
hypothesis should be tested under experimental or natural
challenge conditions.
In conclusion, sera and whey from pregnant heifers
immunized with S. aureus whole or lysed cells formulated
with a classical adjuvant and ISCOM Matrix stimulated
antibodies production that inhibited internalization in
MEC and increased phagocytosis by milk macrophages,
providing insight into the putative mechanism by which
these vaccines can afford protection to the mammary
gland against S. aureus IMI.
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